Market closed

Nautilus Biotechnolgy/$NAUT

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Nautilus Biotechnolgy

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Ticker

$NAUT
Trading on

Industry

Life Sciences Tools & Services

Employees

161

NAUT Metrics

BasicAdvanced
$221M
Market cap
-
P/E ratio
-$0.56
EPS
1.03
Beta
-
Dividend rate
$221M
1.03
$3.45
$1.74
166K
16.648
16.233
12.356
14.128
-17.62%
-28.04%
0.99
0.99
-3.612
16.57%
-4.14%

What the Analysts think about NAUT

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Nautilus Biotechnolgy stock.

NAUT Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

NAUT Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NAUT

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Nautilus Biotechnolgy stock?

Nautilus Biotechnolgy (NAUT) has a market cap of $221M as of December 21, 2024.

What is the P/E ratio for Nautilus Biotechnolgy stock?

The price to earnings (P/E) ratio for Nautilus Biotechnolgy (NAUT) stock is 0 as of December 21, 2024.

Does Nautilus Biotechnolgy stock pay dividends?

No, Nautilus Biotechnolgy (NAUT) stock does not pay dividends to its shareholders as of December 21, 2024.

When is the next Nautilus Biotechnolgy dividend payment date?

Nautilus Biotechnolgy (NAUT) stock does not pay dividends to its shareholders.

What is the beta indicator for Nautilus Biotechnolgy?

Nautilus Biotechnolgy (NAUT) has a beta rating of 1.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.